A combination therapy of metformin, diet, exercise and PPC in patients with type 2 diabetes was more effective than
metformin, diet and exercise alone. The same was the case
for the combination therapy of PPC with UDCA. No relevant side-effects were reported.
"Based on the pharmacological and clinical data, PPC would appear to be the drug of choice for significantly reducing or abolishing fatty liver of different origin, e.g.